A specialized brain scan found nerve connection loss in people with MS, including damage beyond the areas seen on MRI.
Researchers checked whether the scan could measure nerve connections in brain tissue. In mice with MS-like brain damage, the scan detected nerve connection loss in damaged areas. The scan also detected this loss in people with MS. It found affected areas more than 20 times larger than the damaged areas seen on MRI. Larger affected areas were linked to greater disability and lower scores on thinking tests.
The researchers studied people with MS at different stages and mice with MS-like brain damage. The study focused on damage to the brain's outer layer. The scan found nerve connection loss in damaged areas of the participants' brains. People with progressive MS had larger affected areas on these scans. The findings suggest this scan may help researchers track damage linked to disability and thinking.
You should know this study included 31 people with MS and also used mice. The abstract does not say whether the scan can predict how an individual's MS will change. It also does not show that using the scan improves care.
AI-generated summary — for informational purposes only, not medical advice
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More10/9/2026
A mouse study suggests prepared red blood cells may calm MS-like immune attacks. Learn why liver cel
Read More10/9/2026
See how lab-grown nerve cells move a key protein, why this may matter for nerve health, and why the
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Science translational medicine often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.